Market Tracker

08/24 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

32.46
Delayed Data
As of 3:59pm ET
 -1.90 / -5.53%
Today’s Change
16.64
Today|||52-Week Range
43.89
-8.95%
Year-to-Date
3 Biotech Stocks With Explosive Upside Potential
Aug 23 / MotleyFool.com - Paid Partner Content
5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call
Aug 11 / MotleyFool.com - Paid Partner Content
Bret Jensen Reporting for Duty
Aug 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close34.36
Today’s open34.36
Day’s range32.33 - 35.34
Volume2,340,766
Average volume (3 months)2,454,075
Market cap$4.1B
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-34.28%
Earnings growth (next 5 years)+9.45%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book17.53

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-8.64-5.17%
IONSIonis Pharmaceutical...-2.07-6.14%
PTHNPatheon NV-0.26-0.93%
GRFSGrifols SA-0.27-1.63%
Data as of 4:00pm ET, 08/24/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts